Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2022 Jul;26(3):408-414.
doi: 10.1111/hdi.13007. Epub 2022 Feb 3.

Pruritus-reducing effects of omega-3 fatty acids in hemodialysis patients: A cross-over randomized clinical trial

Ali Forouhari  1 , Masoud Moghtaderi  2 , Sina Raeisi  1 , Shahrzad Shahidi  3 , Zahra Parin Hedayati  3 , Jinoos Zaboliyan  4 , Sima Ani  4 , Firouzeh Moeinzadeh  3 , Mojgan Mortazavi  3
Affiliations
Randomized Controlled Trial

Pruritus-reducing effects of omega-3 fatty acids in hemodialysis patients: A cross-over randomized clinical trial

Ali Forouhari et al. Hemodial Int. 2022 Jul.

Abstract

Introduction: Chronic kidney disease-associated pruritus is a common complication in patients with end-stage renal disease. In this study, we have explored the outcome of omega-3 supplementary intake for the treatment of this symptom.

Methods: This double-blinded, randomized, crossover study was conducted in two dialysis centers in which 40 hemodialysis patients suffering from pruritus were randomly assigned into two groups (Group A and Group B). Patients in Group A consumed omega-3 capsules for 4 weeks and after a washout period (6 weeks), they took placebo for another 4 weeks. The same was performed in Group B but in the reverse order. Pruritus score was determined at the baseline, Week 4, 10, and 14. Serum levels of prostaglandin E2 were also recorded at the baseline and Week 4.

Results: There was a statistically significant reduction of pruritus score in patients who took the omega-3 fatty acid supplement. The mean pruritus score decreased significantly in both first (-3.41 ± 2.62, p < 0.001) and second (-1.00 ± 1.84, p = 0.04) treatment period after omega-3 treatment; but no significant mean pruritus score difference in placebo group after both intervention periods was observed. The decrease in prostaglandin E2 amount was not statistically significant in the intervention (omega-3) group compared to the placebo group (p = 0.204).

Discussion: Our observations indicate that omega-3 fatty acids (3 grams per day) have decreasing effects on pruritus. Also, reduction in prostaglandin E2 levels in the omega-3 group did not differ from the changes in the placebo group.

Keywords: CKD-aP; chronic kidney disease; hemodialysis; omega-3 fatty acids; prostaglandin E2; pruritus.

PubMed Disclaimer

References

REFERENCES

    1. Heydarbaki M, Amerian M, Abbasi A, Amanpour F, Mohammadpourhodki R, Ebrahimi H. The effects of omega-3 on the sleep quality of patients with uremic pruritus undergoing hemodialysis: a randomized crossover study. J Complement Integr Med. 2020;18(1):217-22.
    1. Bikbov B, Purcell CA, Levey AS, Smith M, Abdoli A, Abebe M, et al. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the global burden of disease study 2017. The Lancet. 2020;395(10225):709-33.
    1. Verduzco HA, Shirazian S. CKD-associated pruritus: new insights into diagnosis, pathogenesis, and management. Kidney Int Rep. 2020;5(9):1387-402.
    1. Rehman IU, Chohan TA, Bukhsh A, Khan TM. Impact of pruritus on sleep quality of hemodialysis patients: a systematic review and meta-analysis. Medicina. 2019;55(10):699.
    1. Panahi Y, Dashti-Khavidaki S, Farnood F, Noshad H, Lotfi M, Gharekhani A. Therapeutic effects of Omega-3 fatty acids on chronic kidney disease-associated pruritus: a literature review. Adv Pharm Bull. 2016;6(4):509-14.

Publication types

LinkOut - more resources